Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Drugs for Vancomycin-Resistant Enterococcus Faecium Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Status and Forecast (2016-2027)
      • 1.3.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Supply by Company

    • 2.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume by Company
    • 2.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Value by Company
    • 2.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Price by Company
    • 2.4 Drugs for Vancomycin-Resistant Enterococcus Faecium Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Drugs for Vancomycin-Resistant Enterococcus Faecium Market Status by Category

    • 3.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Category Introduction
      • 3.1.1 Daptomycin
      • 3.1.2 Linezolid
      • 3.1.3 Quinupristin/dalfopristin
      • 3.1.4 Ampicillin
      • 3.1.5 Chloramphenicol
      • 3.1.6 Others
    • 3.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market by Category
      • 3.2.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume by Category (2016-2021)
      • 3.2.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Value by Category (2016-2021)
      • 3.2.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Drugs for Vancomycin-Resistant Enterococcus Faecium Market Status by End User/Segment

    • 4.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Segment by End User/Segment
      • 4.1.1 Hospital
      • 4.1.2 Clinic
      • 4.1.3 Others
    • 4.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market by End User/Segment
      • 4.2.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Status by Region

    • 5.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market by Region
      • 5.1.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume by Region
      • 5.1.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Value by Region
    • 5.2 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Status
    • 5.3 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Status
    • 5.4 Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Status
    • 5.5 Central & South America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Status
    • 5.6 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Status

    6 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Status

    • 6.1 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market by Country
      • 6.1.1 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume by Country (2016-2021)
      • 6.1.2 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Status

    • 7.1 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market by Country
      • 7.1.1 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Status

    • 8.1 Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market by Country
      • 8.1.1 Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Status

    • 9.1 Central & South America Drugs for Vancomycin-Resistant Enterococcus Faecium Market by Country
      • 9.1.1 Central & South America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Status

    • 10.1 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market by Country
      • 10.1.1 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Drugs for Vancomycin-Resistant Enterococcus Faecium Manufacturing Cost Analysis
    • 11.5 Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Channel and Distributors Analysis
      • 11.5.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Channel
      • 11.5.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Distributors
    • 11.6 Drugs for Vancomycin-Resistant Enterococcus Faecium Downstream Major Buyers

    12 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast by Category and by End User/Segment

    • 12.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Forecast by Category
      • 12.2.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume Forecast by Category
      • 12.2.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Value Forecast by Category
      • 12.2.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Price Forecast by Category
    • 12.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Forecast by End User/Segment
      • 12.3.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Value Forecast by End User/Segment
      • 12.3.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Price Forecast by End User/Segment

    13 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast by Region/Country

    • 13.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Forecast by Region (2022-2027)
      • 13.1.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Microbiotix
      • 14.1.1 Company Information
      • 14.1.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Introduction
      • 14.1.3 Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 MGB Biopharma Limited
      • 14.2.1 Company Information
      • 14.2.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Introduction
      • 14.2.3 MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Lytix Biopharma
      • 14.3.1 Company Information
      • 14.3.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Introduction
      • 14.3.3 Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 LegoChem Biosciences
      • 14.4.1 Company Information
      • 14.4.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Introduction
      • 14.4.3 LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Helix BioMedix
      • 14.5.1 Company Information
      • 14.5.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Introduction
      • 14.5.3 Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Enanta Pharmaceuticals
      • 14.6.1 Company Information
      • 14.6.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Introduction
      • 14.6.3 Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Cellceutix Corporation
      • 14.7.1 Company Information
      • 14.7.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Introduction
      • 14.7.3 Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Aphios Corporation
      • 14.8.1 Company Information
      • 14.8.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Introduction
      • 14.8.3 Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Alvogen
      • 14.9.1 Company Information
      • 14.9.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Introduction
      • 14.9.3 Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Alchemia Limited
      • 14.10.1 Company Information
      • 14.10.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Introduction
      • 14.10.3 Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Drugs for Vancomycin-Resistant Enterococcus Faecium market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Drugs for Vancomycin-Resistant Enterococcus Faecium market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Daptomycin
      Linezolid
      Quinupristin/dalfopristin
      Ampicillin
      Chloramphenicol
      Others

      Segmented by End User/Segment
      Hospital
      Clinic
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Microbiotix
      MGB Biopharma Limited
      Lytix Biopharma
      LegoChem Biosciences
      Helix BioMedix
      Enanta Pharmaceuticals
      Cellceutix Corporation
      Aphios Corporation
      Alvogen
      Alchemia Limited
      Buy now